Keck Graduate Institute (KGI) and City of Hope have a remarkable history of innovation in science and medical care. Our faculty members have made major contributions in translational research and biomedicine, and are widely recognized as leaders in their fields. This program joins two great innovators KGI, dedicated to application-based scientific research and education, and City of Hope, an institution that helped establish the biotechnology industry.

 

KGI was established in response to a call by our nation’s leaders to rethink higher education and embrace an interdisciplinary approach. Bringing together engineering, the life sciences and business, with an emphasis on professional degrees prepares students for careers in clinical and regulatory affairs, pharmaceuticals, bioinstrumentation, medical devices, and biotechnology. The broad, interdisciplinary approach to science education makes KGI graduates of great potential value to a broad range of biotech industry companies and to governmental agencies and nonprofit organizations that are tasked with regulatory responsibilities and the advancement of safe and effective medicines and medical products.

 

City of Hope helped launch the biotech industry by investigators who created the technology that led to the first human recombinant gene products, insulin and human growth hormone, which are now in use by millions of people worldwide. The most recent class of blockbuster drugs, humanized monoclonal antibodies, are based upon a core technology developed by Beckman Research Institute researchers. Both basic science and translational biomedical research flourish here, in a collegial atmosphere where cross-communication thrives and basic science findings are often applied to the cure of life-threatening diseases.

 

We welcomed our inaugural class in 2018 and look forward to the growth of this program. We know that the partnership between the Henry E. Riggs School of Applied Life Sciences at KGI and the Irell & Manella Graduate School of Biological Sciences at City of Hope in offering the MSTM program will serve to our graduates as a great stepping stone to a variety of research careers in biotechnology, pharmaceutical industry, clinical or academic laboratories, as well as doctoral research or medical education.
 

Anastasia Levitin, Ph.D. Professor of Practice in Translational Medicine Henry E. Riggs School of Applied Life Sciences Keck Graduate Institute	Yilun Liu, Ph.D. Professor, Associate Chair Department of Cancer Genetics & Epigenetics Beckman Research Institute City of Hope